Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Selegiline hydrochloride
Focus Pharmaceuticals Ltd
N04BD01
Selegiline hydrochloride
1.25mg
Oral lyophilisate
Oromucosal
No Controlled Drug Status
Valid as a prescribable product
BNF: 04090100